Feature

JVP Labs redefining congestive heart failure monitoring

Closely held JVP Labs is developing the only non-invasive, real-time cardiac filling pressure monitoring solution for managing congestive heart failure (CHF) patients—for both in the hospital and at home.

June 3, 2025

Feature

Eledon leading a paradigm shift in immunosuppression therapy in organ transplantation

Eledon Pharmaceuticals (NASDAQ: ELDN) is pioneering a potential breakthrough in immunosuppression therapy aimed at extending the longevity of transplanted organs and enhancing the overall health and quality of life for...

May 27, 2025

Feature

Longhorn impacting global health challenges by tackling bacterial toxins with vaccine and diagnostics solutions

Closely held Longhorn Vaccines and Diagnostics is developing peptide vaccines and monoclonal antibodies aimed at preventing and reducing the global burden of medical conditions caused by key bacterial toxins, including...

May 20, 2025

Feature

Terns shaping the future of human health with potential best-in-class therapies for serious diseases

Terns Pharmaceuticals (NASDAQ:TERN) is developing a portfolio of novel, oral small-molecule product candidates based on clinically validated mechanisms of action to address serious diseases including oncology and...

May 6, 2025

NEWS

Just a few of the companies we’ve highlighted along the way

Giving healthcare companies and their stories the exposure they deserve.

JVP Labs redefining congestive heart failure monitoring

Eledon leading a paradigm shift in immunosuppression therapy in organ transplantation

Longhorn impacting global health challenges by tackling bacterial toxins with vaccine and diagnostics solutions

Terns shaping the future of human health with potential best-in-class therapies for serious diseases

NEWS

Leonard Wheeler, former NFL player, named global ambassador for Profound’s TULSA-PRO

Dyadic announces leadership change as part of strategic shift

Defence opens first U.S. laboratory

atai and Beckley to combine establishing market leader in psychedelic mental health therapies

Genflow and CER agree to long-term R&D collaboration

enGene appoints Amy Pott as chief global commercialization officer

NeoGenomics introduces PanTracer genomic profiling tests at ASCO 2025

CellCentric appoints Celia Economides as CFO & CBO

Accomplished medtech industry veteran, Laurie Vertuccio, joins Profound Medical as VP of Global Marketing

Just a few of the companies we’ve highlighted along the way

Subscribe